Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

Altered Amygdala Excitation and CB1 Receptor Modulation of Aggressive Behavior in the Neuroligin-3R451C Mouse Model of Autism.

Hosie S, Malone DT, Liu S, Glass M, Adlard PA, Hannan AJ, Hill-Yardin EL.

Front Cell Neurosci. 2018 Aug 3;12:234. doi: 10.3389/fncel.2018.00234. eCollection 2018.

2.

Qualitative evaluation of how a virtual dementia experience impacts medical and pharmacy students' self-reported knowledge and attitudes towards people with dementia.

Gilmartin-Thomas JF, McNeil J, Powell A, Malone DT, Larson IC, O'Reilly CL, Kirkpatrick CM, Kipen E, Petrovich T, Ryan-Atwood TE, Bell JS.

Dementia (London). 2020 Feb;19(2):205-220. doi: 10.1177/1471301218770270. Epub 2018 Apr 16. No abstract available.

PMID:
29661097
3.

Impact of a Virtual Dementia Experience on Medical and Pharmacy Students' Knowledge and Attitudes Toward People with Dementia: A Controlled Study.

Gilmartin-Thomas JF, McNeil J, Powell A, Malone DT, Wolfe R, Larson IC, O'Reilly CL, Kirkpatrick CM, Kipen E, Petrovich T, Bell JS.

J Alzheimers Dis. 2018;62(2):867-876. doi: 10.3233/JAD-170982.

PMID:
29480198
4.

Developing a Framework for Objective Structured Clinical Examinations Using the Nominal Group Technique.

Hussainy SY, Crum MF, White PJ, Larson I, Malone DT, Manallack DT, Nicolazzo JA, McDowell J, Lim AS, Kirkpatrick CM.

Am J Pharm Educ. 2016 Nov 25;80(9):158. doi: 10.5688/ajpe809158.

5.

Positive Allosteric Modulation of the Muscarinic M1 Receptor Improves Efficacy of Antipsychotics in Mouse Glutamatergic Deficit Models of Behavior.

Choy KH, Shackleford DM, Malone DT, Mistry SN, Patil RT, Scammells PJ, Langmead CJ, Pantelis C, Sexton PM, Lane JR, Christopoulos A.

J Pharmacol Exp Ther. 2016 Nov;359(2):354-365. Epub 2016 Sep 14.

PMID:
27630144
6.

Does cannabidiol have a role in the treatment of schizophrenia?

Gururajan A, Malone DT.

Schizophr Res. 2016 Oct;176(2-3):281-290. doi: 10.1016/j.schres.2016.06.022. Epub 2016 Jul 1. Review.

PMID:
27374322
7.

Biased Agonism and Biased Allosteric Modulation at the CB1 Cannabinoid Receptor.

Khajehali E, Malone DT, Glass M, Sexton PM, Christopoulos A, Leach K.

Mol Pharmacol. 2015 Aug;88(2):368-79. doi: 10.1124/mol.115.099192. Epub 2015 Jun 4.

PMID:
26044547
8.

Detection and quantification of allosteric modulation of endogenous m4 muscarinic acetylcholine receptor using impedance-based label-free technology in a neuronal cell line.

Chen AN, Malone DT, Pabreja K, Sexton PM, Christopoulos A, Canals M.

J Biomol Screen. 2015 Jun;20(5):646-54. doi: 10.1177/1087057114563025. Epub 2014 Dec 22.

PMID:
25534830
9.

CB2 receptor agonism reverses MK-801-induced disruptions of prepulse inhibition in mice.

Khella R, Short JL, Malone DT.

Psychopharmacology (Berl). 2014 Aug;231(16):3071-87. doi: 10.1007/s00213-014-3481-x. Epub 2014 Apr 5.

PMID:
24705902
10.

Male contraception via simultaneous knockout of α1A-adrenoceptors and P2X1-purinoceptors in mice.

White CW, Choong YT, Short JL, Exintaris B, Malone DT, Allen AM, Evans RJ, Ventura S.

Proc Natl Acad Sci U S A. 2013 Dec 17;110(51):20825-30. doi: 10.1073/pnas.1318624110. Epub 2013 Dec 2.

11.

Cannabidiol and clozapine reverse MK-801-induced deficits in social interaction and hyperactivity in Sprague-Dawley rats.

Gururajan A, Taylor DA, Malone DT.

J Psychopharmacol. 2012 Oct;26(10):1317-32. doi: 10.1177/0269881112441865. Epub 2012 Apr 9.

PMID:
22495620
12.

A two-hit model: behavioural investigation of the effect of combined neonatal MK-801 administration and isolation rearing in the rat.

Lim AL, Taylor DA, Malone DT.

J Psychopharmacol. 2012 Sep;26(9):1252-64. doi: 10.1177/0269881111430751. Epub 2012 Feb 23.

PMID:
22361477
13.

Consequences of early life MK-801 administration: long-term behavioural effects and relevance to schizophrenia research.

Lim AL, Taylor DA, Malone DT.

Behav Brain Res. 2012 Feb 1;227(1):276-86. doi: 10.1016/j.bbr.2011.10.052. Epub 2011 Nov 9. Review.

PMID:
22085878
14.

The design, synthesis and biological evaluation of novel URB602 analogues as potential monoacylglycerol lipase inhibitors.

Szabo M, Agostino M, Malone DT, Yuriev E, Capuano B.

Bioorg Med Chem Lett. 2011 Nov 15;21(22):6782-7. doi: 10.1016/j.bmcl.2011.09.038. Epub 2011 Sep 18.

PMID:
21982493
15.

Effect of cannabidiol in a MK-801-rodent model of aspects of schizophrenia.

Gururajan A, Taylor DA, Malone DT.

Behav Brain Res. 2011 Sep 23;222(2):299-308. doi: 10.1016/j.bbr.2011.03.053. Epub 2011 Mar 31.

PMID:
21458498
16.

Schizophrenia: a systematic review of the disease state, current therapeutics and their molecular mechanisms of action.

Shin JK, Malone DT, Crosby IT, Capuano B.

Curr Med Chem. 2011;18(9):1380-404. Review.

PMID:
21366526
17.

Isolation rearing in rats: effect on expression of synaptic, myelin and GABA-related immunoreactivity and its utility for drug screening via the subchronic parenteral route.

Lim AL, Taylor DA, Malone DT.

Brain Res. 2011 Mar 24;1381:52-65. doi: 10.1016/j.brainres.2011.01.017. Epub 2011 Jan 15.

PMID:
21241674
18.

Heterogeneity amongst 5-HT₃ receptor subunits: is this significant?

Yaakob N, Malone DT, Exintaris B, Irving HR.

Curr Mol Med. 2011 Feb;11(1):57-68. Review.

PMID:
21189117
19.

Current pharmacological models of social withdrawal in rats: relevance to schizophrenia.

Gururajan A, Taylor DA, Malone DT.

Behav Pharmacol. 2010 Dec;21(8):690-709. doi: 10.1097/FBP.0b013e32833fa7df. Review. Erratum in: Behav Pharmacol. 2011 Jun;22(3):281.

PMID:
20847646
20.

Adolescent cannabis use and psychosis: epidemiology and neurodevelopmental models.

Malone DT, Hill MN, Rubino T.

Br J Pharmacol. 2010 Jun;160(3):511-22. doi: 10.1111/j.1476-5381.2010.00721.x. Review.

21.

The effect of social isolation on rat brain expression of genes associated with endocannabinoid signaling.

Robinson SA, Loiacono RE, Christopoulos A, Sexton PM, Malone DT.

Brain Res. 2010 Jul 9;1343:153-67. doi: 10.1016/j.brainres.2010.04.031. Epub 2010 Apr 27.

PMID:
20430015
22.

Characterisation of the prostanoid receptor mediating inhibition of smooth muscle contractility in the rat prostate gland.

Tokanovic S, White CW, Malone DT, Exintaris B, Ventura S.

Naunyn Schmiedebergs Arch Pharmacol. 2010 Apr;381(4):321-8. doi: 10.1007/s00210-010-0492-y. Epub 2010 Feb 24.

PMID:
20180098
23.

Effect of testing conditions on the propsychotic action of MK-801 on prepulse inhibition, social behaviour and locomotor activity.

Gururajan A, Taylor DA, Malone DT.

Physiol Behav. 2010 Jan 12;99(1):131-8. doi: 10.1016/j.physbeh.2009.11.005.

PMID:
19931287
24.

Cannabidiol reverses the reduction in social interaction produced by low dose Delta(9)-tetrahydrocannabinol in rats.

Malone DT, Jongejan D, Taylor DA.

Pharmacol Biochem Behav. 2009 Aug;93(2):91-6. doi: 10.1016/j.pbb.2009.04.010. Epub 2009 Apr 23.

PMID:
19393686
25.

Effect of social isolation on CB1 and D2 receptor and fatty acid amide hydrolase expression in rats.

Malone DT, Kearn CS, Chongue L, Mackie K, Taylor DA.

Neuroscience. 2008 Mar 3;152(1):265-72.

26.

Stimulation of epithelial CB1 receptors inhibits contractions of the rat prostate gland.

Tokanovic S, Malone DT, Ventura S.

Br J Pharmacol. 2007 Jan;150(2):227-34. Epub 2006 Nov 13.

27.

The effect of Delta9-tetrahydrocannabinol on sensorimotor gating in socially isolated rats.

Malone DT, Taylor DA.

Behav Brain Res. 2006 Jan 6;166(1):101-9. Epub 2005 Sep 6.

PMID:
16143410
28.

Cannabidiol reverses MK-801-induced disruption of prepulse inhibition in mice.

Long LE, Malone DT, Taylor DA.

Neuropsychopharmacology. 2006 Apr;31(4):795-803.

29.

The effect of SR 141716 and apomorphine on sensorimotor gating in Swiss mice.

Malone DT, Long LE, Taylor DA.

Pharmacol Biochem Behav. 2004 Apr;77(4):839-45.

PMID:
15099930
30.

Involvement of somatodendritic 5-HT(1A) receptors in Delta(9)-tetrahydrocannabinol-induced hypothermia in the rat.

Malone DT, Taylor DA.

Pharmacol Biochem Behav. 2001 Jul-Aug;69(3-4):595-601.

PMID:
11509221
32.

Supplemental Content

Loading ...
Support Center